Clinical trial
Euphorbia Kansui in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir
NCT04503928 is registered in ClinicalTrials.gov with Shanghai Public Health Clinical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Euphorbia Kansui in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir
- Lead sponsor
- Shanghai Public Health Clinical Center
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 31, 2020
- Completion date
- December 31, 2022
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1-infection